ARCH Venture Fund IX, L.P.
CIK: 0001666306
ARCH Venture Fund IX, L.P.'s purchase track record
ARCH Venture Fund IX, L.P. has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/2/2024 | BOLD | $3.20M | -68.4% | -76.1% | +9.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| BOLD | ▲ Buy | Option Exercise | 16,000 | $16K | 7/1/2026 | View on chart |
| BOLD | ▼ Sell | Open Market | 16,000 | $40K | 7/1/2026 | View on chart |
| BOLD | ▼ Sell | Other | 787,545 | — | 4/2/2024 | View on chart |
| BOLD | ▼ Sell | Other | 1,048,433 | — | 4/2/2024 | View on chart |
| BOLD | ▲ Buy | Open Market | 66,667 | $1.1M | 4/2/2024 | View on chart |
| BOLD | ▲ Buy | Open Market | 133,333 | $2.1M | 4/2/2024 | View on chart |
| BOLD | ▼ Sell | Other | 589,743 | — | 4/2/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
BOLD trades near support amid sector news
Recent headlines focus on Beam Therapeutics and Callio Therapeutics rather than direct developments for Boundless Bio. The stock is currently trading near its identified support level, with technical indicators showing a breakdown signal. Analysts maintain a single price target of $4.00, which sits above the current trading range.
BOLD trades near support amid sector news. Recent headlines focus on Beam Therapeutics and Callio Therapeutics rather than direct developments for Boundless Bio. The stock is currently trading near its identified support level, with technical indicators showing a breakdown signal. Analysts maintain a single price target of $4.00, which sits above the current trading range.